Transpyloric Shuttle Meets Endpoints for Obesity Treatment – Medscape

Read article - Richard Rothstein, the Joseph M. Huber Professor and chair of medicine, recently attended Obesity Week 2018 to present the results from the nine-site ENDOBesity II study of a novel investigational weight-loss device called the TransPyloric Shuttle. The study found that the device was safe and effective in a 12-month, phase 3 pivotal trial.